1.
|
Phase: Phase IV Type: Treatment Status: Active Age: Over 55 Sponsor: Other Protocol IDs: GMALL02, NCT00198978
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL01, NCT00198991
|
|
3.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL03, NCT00199004
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Active Age: Over 15 Sponsor: Other Protocol IDs: GMALL05, NCT00199082
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Active Age: 65 and under Sponsor: Other Protocol IDs: LAL-Ph-2000, NCT00526305
|
|
6.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL04, NCT00199017
|
|
7.
|
Phase: Phase IV Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: LAL-AR/2003, NCT00853008
|
|
8.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: PETAL trial, EudraCT-Number 2006-001641-33, Krebshilfe Grant 107592, NCT00554164
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 55 Sponsor: Other Protocol IDs: 9L-03-1, NCT00184041
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and under Sponsor: Other Protocol IDs: ALLR17, NCT00186875
|
|
11.
|
Phase: No phase specified Type: Treatment Status: Active Age: 1 to 18 Sponsor: Other Protocol IDs: GER-COALL-07-03, EU-205104, NCT00343369
|